abstract |
Provided are compounds that activate the sphingosine-1-phosphate receptor of subtype 1. Any compound selectively activates receptor subtype 1 over sphingosine-1-phosphate receptor subtype 3. The use and method of the compounds of the present invention in the treatment of abnormalities in which activation, affinity, inhibition or antagonism of S1P1 is medically prescribed. |